Optimization, physicochemical stability and in vivo study of alginate-chitosan composites as nanocarriers for low molecular weight angiotensin I-converting enzyme (ACE)-inhibitory peptide
Journal of Food and Drug Analysis · 13.09.2024 · 32 (3) · 358-370
DOI: 10.38212/2224-6614.3522 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Food and Drug Analysis, online erschienen am 13.09.2024. Verfasst von Shehu Muhammad Auwal und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Food Science, Faculty of Food Science and Technology, Universiti Putra Malaysia, UPM, 43400, Serdang, Selangor, Malaysia. Hauptthemen laut MEDLINE: Chitosan, Alginates, Angiotensin-Converting Enzyme Inhibitors, Nanoparticles. Die Arbeit wurde bisher 10-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Chitosan and alginate, are non-toxic and biodegradable polymers used to enhance the stability of biotherapeutics by loading them into nanocarriers. In this study, the stone fish-derived low molecular weight peptide (Ala-Leu-Gly-Pro-Gln-Phe-Tyr), exhibited an in vitro ACE-inhibitory activity of 94.43 ± 2.05% and an IC50 of 0.012 ± 0.001 mM. The peptide was encapsulated via ionic gelation with alginate followed by polyelectrolyte complexation with chitosan. The resulting ACE-inhibitory peptide-loaded alginate-chitosan nanoparticles (ACE-I-ALG-CS NPs) were optimized to achieve small particle size (212.60 nm) and high encapsulation efficiency (EE, 74.48%). This was based on an optimum chitosan concentration (0.420%w/v), homogenization speed (6000 rpm), and homogenization time (30 min) using Box Behnken experimental design (BBED). Characterization of the ACE-I-ALG-CS NPs revealed a spherical, monodispersed morphology with high physicochemical stability during storage at 2°C, 7°C, and 12°C for 12 weeks. Moreover, the in vivo study conducted on spontaneously hypertensive rats (SHRs) demonstrated a significantly higher (p < 0.05) systolic blood pressure (SBP)-lowering effect of the ACE-I-ALG-CS NPs compared to captopril and unencapsulated peptide. Hence, alginate and chitosan can be used as biocompatible coating materials to enhance the stability and in vivo antihypertensive effect of Ala-Leu-Gly-Pro-Gln-Phe-Tyr through encapsulation, thereby making it otentially valuable for various applications in pharmaceuticals and food industry.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Food Science, Faculty of Food Science and Technology, Universiti Putra Malaysia, UPM, 43400, Serdang, Selangor, Malaysia.
- Department of Biochemistry, Faculty of Basic Medical Sciences, Bayero University, Kano 700231, Nigeria.
Zitieren
APA
Auwal, S. M., Ghanisma, S. B. M., & Saari, N. (2024). Optimization, physicochemical stability and in vivo study of alginate-chitosan composites as nanocarriers for low molecular weight angiotensin I-converting enzyme (ACE)-inhibitory peptide. Journal of Food and Drug Analysis, 32(3), 358-370. https://doi.org/10.38212/2224-6614.3522
Vancouver
Auwal SM, Ghanisma SBM, Saari N. Optimization, physicochemical stability and in vivo study of alginate-chitosan composites as nanocarriers for low molecular weight angiotensin I-converting enzyme (ACE)-inhibitory peptide. Journal of Food and Drug Analysis. 2024;32(3):358-370. doi:10.38212/2224-6614.3522
BibTeX
@article{Auwal2024,
author = {Auwal, Shehu Muhammad and Ghanisma, Siti Balqis Muhammad and Saari, Nazamid},
title = {Optimization, physicochemical stability and in vivo study of alginate-chitosan composites as nanocarriers for low molecular weight angiotensin I-converting enzyme (ACE)-inhibitory peptide},
journal = {Journal of Food and Drug Analysis},
year = {2024},
volume = {32},
number = {3},
pages = {358--370},
doi = {10.38212/2224-6614.3522}
}
EUVIMED